Brief S2k guidelines - Cutaneous squamous cell carcinoma;S2k Kurzleitlinie - Plattenepithelkarzinom der Haut

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue SUPPL. 3, 2013, Pages 37-45

  Breuninger, Helmut ^a   Eigentler, Thomas ^a   Bootz, Friedrich ^b   Hauschild, Axel ^c   Kortmann, Rolf Dieter ^d   Wolff, Klaus ^e   Stockfleth, Eggert ^f   Szeimies, Rolf Markus ^g   Rompel, Rainer ^h   Garbe, Claus ^a   Grabbe, Stephan ⁱ  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g Knappschaftskrankenhaus Recklinghausen   (Germany)

^h KLINIKUM KASSEL   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

13 CIS RETINOID; ALPHA2A INTERFERON; ARSENIC; BLEOMYCIN; CETUXIMAB; CISPLATIN; FLUOROURACIL; GEFITINIB; IMIQUIMOD; RETINOID DERIVATIVE; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INFILTRATION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CONTINUOUS INFUSION; CRYOTHERAPY; CURETTAGE; ERYTHROPLASIA; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATINIZATION; KERATOACANTHOMA; LOCAL THERAPY; LOW LEVEL LASER THERAPY; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; MALIGNANT TRANSFORMATION; MULTIMODALITY CANCER THERAPY; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RADIATION EXPOSURE; SENTINEL LYMPH NODE BIOPSY; SKIN CARCINOMA; ULTRAVIOLET RADIATION;

CARCINOMA, SQUAMOUS CELL; DERMATOLOGY; GERMANY; HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; SKIN NEOPLASMS;

EID: 84876205440     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12015_7     Document Type: Article

References (28)

1. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer - the role of sunlight. Adv Exp Med Biol 2008; 624: 89-103.
2. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149: 1200-6.
3. Brantsch KD, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous- cell carcinoma: a prospective study. Lancet Oncol 2008; 9: 713-20.
4. Givi B, Andersen PE, Diggs BS, et al. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck 2011; 33: 999-1004.
5. English DR, Armstrong BK, Kricker A, et al. Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: a case-control study. Int J Cancer 1998; 76: 628-34.
6. Criscione VD, Weinstock MA, Naylor MF, et al. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009; 115: 2523-30.
7. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1: 795-7.
8. Breuninger H, Schaumburg-Lever G, Holzschuh J, et al. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 1997; 79: 915-9.
9. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-16.
10. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours (Uicc International Union Against Cancer) (ed 7), John Wiley & Sons, 2009.
11. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual (ed 7). New York, Dordrecht, Heidelberg, London, Springer, 2009.
12. Hoetzenecker W, Guenova E, Bottinger TU, et al. Mapping of specific sentinel node locations for skin cancer of the head. Eur J Dermatol 2011; 21(3): 354-8.
13. Clark RR, Soutar DS. Lymph node metastases from auricular squamous cell carcinoma. A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 2008; 61: 1140-7.
14. Häfner HM, Breuninger H, Moehrle M, et al. 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome. Int J Oral Maxillofac Surg 2011; 40(9): 943-8.
15. Mendenhall WM, Amdur RJ, Hinerman RW, et al. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 2009; 119: 1994-9.
16. Brewster AM, Lee JJ, Clayman GL, et al. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol 2007; 25: 1974-8.
17. Cartei G, Cartei F, Interlandi G, et al. Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged. Am J Clin Oncol 2000; 23: 181-4.
18. Sadek H, Azli N, Wendling JL, et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5- fluorouracil, and bleomycin. Cancer 1990; 66: 1692-6.
19. Khansur T, Kennedy A. Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin. Cancer 1991; 67: 2030-2.
20. Glisson BS, Kim ES, Kies MS, et al. Phase II study of gefitinib in patients with metastatic/recurrent squamous cell carcinoma of the skin. J Clin Oncol ASCO Annual Meeting Proceedings Part I. Vol 24, 2006.
21. Maubec E, Petrow P, Duvillard P, et al. Cetuximab as first-line monotherapy in patients with unresectable squamous cell carcinoma of the skin: Preliminary results of a phase II multicenter study. J Clin Oncol 2008; 26: (abstr 9042).
22. Lippman SM, Parkinson DR, Itri LM, et al. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992; 84: 235-41.
23. Shin DM, Glisson BS, Khuri FR, et al. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol 2002; 20: 364-70.
24. Mehnert A, Petersen C, Koch U. Empfehlungen zur Psychoonkologischen Versorgung im Akutkrankenhaus. Zeitschrift für Medizinische Psychologie 2003; 12: 77-84.
25. Loscalzo M, Clark KL, Holland J. Successful strategies for implementing biopsychosocial screening. Psycho-Oncology 2011; 20: 455-62.
26. Holland JC, Andersen B, Breitbart W. Distress Management. J Natl Compr Canc Netw 2010; 8: 448-85.
27. Strittmatter G. Psychosoziale Betreuung von Patienten mit Hauttumoren in Zeiten der Diagnosis Related Groups (DRG). Hautarzt 2004; 55: 735-45.
28. Aarstad AK, Beisland E, Osthus AA, Aarstad HJ. Distress, quality of life, neuroticism and psychological coping are related in head and neck cancer patients during follow-up. Acta Oncol 2011; 50(3): 390-8.